相关实验视频
Updated: Sep 18, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.7K
雷扎塔波普特:一个有前途的小分子"refolder",专门用于TP53Y220C突变瘤
Kostas A Papavassiliou1, Alice G Vassiliou2, Athanasios G Papavassiliou3
1First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
概括
恢复突变p53的瘤抑制功能 (一种在一半的人类癌症中被禁用的蛋白质) 是治疗目标. 新的研究澄清了p53-Y220C活性剂如何工作,提高了它们的临床潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 突变p53与大约50%的人类癌症有关.
- 恢复野生型p53瘤抑制功能是一个有前途的治疗策略.
- 一些突变的p53活性剂正在临床开发中,包括PC14586 (rezatapopt).
研究的目的:
- 总结关于p53-Y220C反应器化合物的临床前发现.
- 阐明这些反应器的机制和作用.
- 突出在癌症治疗中针对p53突变物的临床影响.
主要方法:
- 从普齐奥-库特等人获得的临床前数据的审查.
- 对p53-Y220C活性化剂化合物的作用机制的分析.
- 对PC14586 (rezatapopt) 的临床试验数据的评估.
主要成果:
- 在第一阶段试验中,PC14586 (rezatapopt) 显示了初步的疗效和良好的安全性.
- 新的数据增强了对p53-Y220C活性化剂化合物机制的理解.
- 向p53突变体显示出癌症治疗中的巨大潜力.
结论:
- 需要进一步的研究才能充分实现p53突变重激活剂的治疗潜力.
- 了解这些化合物的机制对于优化其使用至关重要.
- 针对特定的p53突变,如Y220C,为癌症治疗提供了合理的方法.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Negative Regulator Molecules
36.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K

